Zhang et al. [199] proposed an acidity modulation combined with programmed death ligand-1 (PD-L1) siRNA (siPD-L1) strategy for synergistically enhancing tumor immunotherapy (Fig. 8D). This evidence concerns the gene CD274 and neoplasm.